HIV molecular immunology database
MRVRGIQTSWQNLWR
|
gp160(1-12) | human epitope |
MRVKEKYQHLWRWGW
|
gp160(1-15) | human epitope |
MKVKGIRKNWHNLGKWGS
|
gp160(1-19) | human epitope |
MKVrGIRKNWHNLGKWGS
|
gp160(1-19) | observed variant |
RVKEKYQHL
|
gp160(2-10) | B*08 human epitope |
RVKEKYQHL
|
gp160(2-10) | B*08:01 human epitope |
RVKEKYQHL
|
gp160(2-10) | B*08:01 human epitope |
RVKEKYQHL
|
gp160(2-10) | B8 human epitope |
RVKgirknYQHL
|
gp160(2-10) | non-susceptible form |
RVKEKYQHL
|
gp160(2-10) | B8 epitope |
GIRKNYQHLWRGGTL
|
gp160(2-16) | mouse epitope |
RKNYQHLWK
|
gp160(4-12) | human epitope |
TQMNWPNLWK
|
gp160(6-12) | A*11 human epitope |
TQMNWPNLWK
|
gp160(6-12) | A11 human epitope |
NYQHLWRGGIMLLWRGIM
|
gp160(6-20) | human epitope |
NYQHLWRGGIsLLWRGIM
|
gp160(6-20) | inferred escape |
NYQHwWRGGIMLLWRGIM
|
gp160(6-20) | inferred escape |
NYQHLWRGGIMLLWRGIM
|
gp160(6-20) | human epitope |
NYQHLWRGGIsLLWRGIM
|
gp160(6-20) | observed variant |
LWRWGTMLLGMLMIC
|
gp160(14-28) | mouse epitope |
GTLLLGMLMICSAVE
|
gp160(18-32) | mouse epitope |